Literature DB >> 30199707

Role of p53 circuitry in tumorigenesis: A brief review.

Sarfaraj Niazi1, Madhusudan Purohit2, Javed H Niazi3.   

Abstract

Maintenance of genome integrity under the stressed condition is paramount for normal functioning of cells in the multicellular organisms. Cells are programmed to protect their genome through specialized adaptive mechanisms which will help decide their fate under stressed conditions. These mechanisms are the outcome of activation of the intricate circuitries that are regulated by the p53 master protein. In this paper, we provided a comprehensive review on p53, p53 homologues and their isoforms, including a description about the ubiquitin-proteasome system emphasizing its role in p53 regulation. p53 induced E3(Ub)-ligases are an integral part of the ubiquitin-proteasome system. This review outlines the roles of important E3(Ub)-ligases and their splice variants in maintaining cellular p53 protein homeostasis. It also covers up-to-date and relevant information on small molecule Mdm2 inhibitors originated from different organizations. The review ends with a discussion on future prospects and investigation directives for the development of next-generation modulators as p53 therapeutics.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  COP1; Mdm2; Modulators; Pharmacophore; Pirh2; Proteasome; Ubiquitin; miRNA; p53

Mesh:

Substances:

Year:  2018        PMID: 30199707     DOI: 10.1016/j.ejmech.2018.08.099

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  18 in total

1.  The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.

Authors:  G R Tundo; D Sbardella; A M Santoro; A Coletta; F Oddone; G Grasso; D Milardi; P M Lacal; S Marini; R Purrello; G Graziani; M Coletta
Journal:  Pharmacol Ther       Date:  2020-05-19       Impact factor: 12.310

2.  Ubiquitination of P53 by E3 ligase MKRN2 promotes melanoma cell proliferation.

Authors:  Yiling Zhang; Ningning Cui; Gang Zheng
Journal:  Oncol Lett       Date:  2020-01-08       Impact factor: 2.967

Review 3.  Interplay between HMGA and TP53 in cell cycle control along tumor progression.

Authors:  Nathalia Meireles Da Costa; Antonio Palumbo; Marco De Martino; Alfredo Fusco; Luis Felipe Ribeiro Pinto; Luiz Eurico Nasciutti
Journal:  Cell Mol Life Sci       Date:  2020-09-12       Impact factor: 9.261

Review 4.  Anticancer Actions of Azurin and Its Derived Peptide p28.

Authors:  Fan Huang; Qianhui Shu; Zhaojie Qin; Jianglin Tian; Zhengding Su; Yongqi Huang; Meng Gao
Journal:  Protein J       Date:  2020-04       Impact factor: 2.371

Review 5.  Ubiquitin-proteasome system-targeted therapy for uveal melanoma: what is the evidence?

Authors:  Chen-Xi Zhao; Chen-Ming Zeng; Ke Wang; Qiao-Jun He; Bo Yang; Fan-Fan Zhou; Hong Zhu
Journal:  Acta Pharmacol Sin       Date:  2020-06-29       Impact factor: 6.150

Review 6.  The roles of ribosomal proteins in nasopharyngeal cancer: culprits, sentinels or both.

Authors:  Edmund Ui-Hang Sim; Choon-Weng Lee; Kumaran Narayanan
Journal:  Biomark Res       Date:  2021-06-30

7.  Tumor suppressor OTUD3 induces growth inhibition and apoptosis by directly deubiquitinating and stabilizing p53 in invasive breast carcinoma cells.

Authors:  Qian Pu; Yan-Rong Lv; Ke Dong; Wen-Wen Geng; Hai-Dong Gao
Journal:  BMC Cancer       Date:  2020-06-22       Impact factor: 4.430

Review 8.  Advances in targeted degradation of endogenous proteins.

Authors:  Sascha Röth; Luke J Fulcher; Gopal P Sapkota
Journal:  Cell Mol Life Sci       Date:  2019-04-27       Impact factor: 9.261

Review 9.  Role of Dietary Antioxidants in p53-Mediated Cancer Chemoprevention and Tumor Suppression.

Authors:  J P Jose Merlin; H P Vasantha Rupasinghe; Graham Dellaire; Kieran Murphy
Journal:  Oxid Med Cell Longev       Date:  2021-06-26       Impact factor: 6.543

10.  KRAB domain of ZFP568 disrupts TRIM28-mediated abnormal interactions in cancer cells.

Authors:  Janani Kumar; Gundeep Kaur; Ren Ren; Yue Lu; Kevin Lin; Jia Li; Yun Huang; Anamika Patel; Michelle C Barton; Todd Macfarlan; Xing Zhang; Xiaodong Cheng
Journal:  NAR Cancer       Date:  2020-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.